{"id":"https://openalex.org/W2017883234","doi":"https://doi.org/10.1002/art.21671","title":"Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis","display_name":"Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis","publication_year":2006,"publication_date":"2006-02-28","ids":{"openalex":"https://openalex.org/W2017883234","doi":"https://doi.org/10.1002/art.21671","mag":"2017883234","pmid":"https://pubmed.ncbi.nlm.nih.gov/16508927"},"language":"en","primary_location":{"id":"doi:10.1002/art.21671","doi":"https://doi.org/10.1002/art.21671","is_oa":false,"landing_page_url":"https://doi.org/10.1002/art.21671","pdf_url":null,"source":{"id":"https://openalex.org/S132787887","display_name":"Arthritis & Rheumatism","issn_l":"0004-3591","issn":["0004-3591","1529-0131"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis & Rheumatism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029733252","display_name":"Gertjan Wolbink","orcid":"https://orcid.org/0000-0003-1924-7460","observed_orcids":["https://orcid.org/0000-0003-1924-7460"]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Gerrit Jan Wolbink","raw_affiliation_strings":["Department of Immunopathology, CLB Sanquin Amsterdam and Jan van Breeman Institute, Amsterdam, The Netherlands. G.Wolbink@janvanbreeman.nl","CLB Sanquin Amsterdam and Jan van Breeman Institute, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunopathology, CLB Sanquin Amsterdam and Jan van Breeman Institute, Amsterdam, The Netherlands. G.Wolbink@janvanbreeman.nl","institution_ids":["https://openalex.org/I3020210244"]},{"raw_affiliation_string":"CLB Sanquin Amsterdam and Jan van Breeman Institute, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048956254","display_name":"Marijn Vis","orcid":"https://orcid.org/0000-0002-4402-4165","observed_orcids":["https://orcid.org/0000-0002-4402-4165"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marijn Vis","raw_affiliation_strings":["Slotervaart Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Slotervaart Hospital, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802065108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075695885","display_name":"Willem Frederik Lems","orcid":"https://orcid.org/0000-0002-6885-3953","observed_orcids":["https://orcid.org/0000-0002-6885-3953"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Willem Lems","raw_affiliation_strings":["Slotervaart Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Slotervaart Hospital, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802065108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027096828","display_name":"Alexandre E. Voskuyl","orcid":"https://orcid.org/0000-0002-9699-1827","observed_orcids":["https://orcid.org/0000-0002-9699-1827"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Alexandre E. Voskuyl","raw_affiliation_strings":["VU Medical Center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110069801","display_name":"Els R. de Groot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Els De Groot","raw_affiliation_strings":["CLB Sanquin Amsterdam, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CLB Sanquin Amsterdam, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067384016","display_name":"Michael Twahier Nurmohamed","orcid":"https://orcid.org/0000-0002-6274-1934","observed_orcids":["https://orcid.org/0000-0002-6274-1934"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael T. Nurmohamed","raw_affiliation_strings":["Jan van Breeman Institute, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jan van Breeman Institute, Amsterdam, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057623947","display_name":"Steven O. Stapel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Steven Stapel","raw_affiliation_strings":["CLB Sanquin Amsterdam, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CLB Sanquin Amsterdam, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111669009","display_name":"Paul Peter Tak","orcid":"https://orcid.org/0000-0002-3532-5409","observed_orcids":["https://orcid.org/0000-0002-3532-5409"]},"institutions":[{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Paul P. Tak","raw_affiliation_strings":["University of Amsterdam, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Amsterdam, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112036494","display_name":"Lucien A. Aarden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Lucien Aarden","raw_affiliation_strings":["CLB Sanquin Amsterdam, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CLB Sanquin Amsterdam, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108476892","display_name":"Ben A. C. Dijkmans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ben Dijkmans","raw_affiliation_strings":["VU Medical Center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I911458345"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":16.091,"has_fulltext":false,"cited_by_count":473,"citation_normalized_percentile":{"value":0.99526789,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"54","issue":"3","first_page":"711","last_page":"715"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9609000086784363,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.017799999564886093,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.016100000590085983,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9039999842643738},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.996999979019165},{"id":"https://openalex.org/keywords/tumor-necrosis-factor-inhibitors","display_name":"tumor necrosis factor inhibitors","score":0.7820000052452087},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6549999713897705},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.6919999718666077},{"id":"https://openalex.org/keywords/radioimmunoassay","display_name":"radioimmunoassay","score":0.6949999928474426},{"id":"https://openalex.org/keywords/serum-drug-levels","display_name":"serum drug concentration","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.9161936044692993},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9150336980819702},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.8412760496139526},{"id":"https://openalex.org/C2777489490","wikidata":"https://www.wikidata.org/wiki/Q684924","display_name":"Rheumatism","level":2,"score":0.7453603744506836},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7139943838119507},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.562606930732727},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5409975051879883},{"id":"https://openalex.org/C176685330","wikidata":"https://www.wikidata.org/wiki/Q857638","display_name":"Radioimmunoassay","level":2,"score":0.5147140622138977},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.5002763271331787},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.49962639808654785},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.49399930238723755},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4776143729686737},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.33094191551208496}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000917","descriptor_name":"Antibody Formation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011863","descriptor_name":"Radioimmunoassay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1002/art.21671","doi":"https://doi.org/10.1002/art.21671","is_oa":false,"landing_page_url":"https://doi.org/10.1002/art.21671","pdf_url":null,"source":{"id":"https://openalex.org/S132787887","display_name":"Arthritis & Rheumatism","issn_l":"0004-3591","issn":["0004-3591","1529-0131"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis & Rheumatism","raw_type":"journal-article"},{"id":"pmid:16508927","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16508927","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis and rheumatism","raw_type":"Journal Article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/458fc69c-9985-45e5-bba3-fd33aab1dddd","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/development-of-antiinfliximab-antibodies-and-relationship-to-clinical-response-in-patients-with-rheumatoid-arthritis(458fc69c-9985-45e5-bba3-fd33aab1dddd).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Arthritis and rheumatism, 54(3), 711 - 715. John Wiley and Sons Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/2d27eaab-c56f-4f2b-81ca-1c97a27d19d1","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/2d27eaab-c56f-4f2b-81ca-1c97a27d19d1","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Wolbink, G J, Vis, M, Lems, W, Voskuyl, A E, de Groot, E, Nurmohamed, M T, Stapel, S, Tak, P P, Aarden, L & Dijkmans, B 2006, 'Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis', Arthritis and rheumatism, vol. 54, no. 3, pp. 711-715. https://doi.org/10.1002/art.21671","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/9eaee3db-ba6a-472c-b38c-e87a48f60da2","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/9eaee3db-ba6a-472c-b38c-e87a48f60da2","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Wolbink, G J, Vis, M, Lems, W, Voskuyl, A E, de Groot, E, Nurmohamed, M T, Stapel, S, Tak, P P, Aarden, L & Dijkmans, B 2006, 'Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis', Arthritis and rheumatism, vol. 54, no. 3, pp. 711-5. https://doi.org/10.1002/art.21671","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vumc:oai:pure.atira.dk:publications/cfdfd2ee-48cc-4360-818a-fe7dd1927e64","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/cfdfd2ee-48cc-4360-818a-fe7dd1927e64","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Arthritis and Rheumatism, 54(3), 711 - 5. John Wiley and Sons Inc.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W83712841","https://openalex.org/W1996472975","https://openalex.org/W1997999969","https://openalex.org/W2000905503","https://openalex.org/W2040505385","https://openalex.org/W2050154180","https://openalex.org/W2051986755","https://openalex.org/W2065419533","https://openalex.org/W2097148639","https://openalex.org/W2110177517","https://openalex.org/W2143531159","https://openalex.org/W2152348310","https://openalex.org/W2159106700","https://openalex.org/W4210493554"],"related_works":["https://openalex.org/W2326180639","https://openalex.org/W2111046066","https://openalex.org/W4323966681","https://openalex.org/W2128729918","https://openalex.org/W2327229730","https://openalex.org/W2123556713","https://openalex.org/W1897160555","https://openalex.org/W2316583770","https://openalex.org/W2523653129","https://openalex.org/W2133832905"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Treatment":[1],"of":[2,20,30,52,64,125,136,150,162,176,186],"patients":[3,34,55,106,130,143,165],"with":[4,35,56,59,61,129,131,167,191],"infliximab,":[5,60],"a":[6,45,50,62,192],"chimeric":[7],"monoclonal":[8],"IgG1":[9],"antibody":[10],"against":[11,100],"tumor":[12],"necrosis":[13],"factor,":[14],"may":[15],"result":[16],"in":[17,33,49,82,104],"the":[18,27,85,92,163,173],"formation":[19],"infliximab-specific":[21],"IgG":[22],"antibodies.":[23,155],"This":[24,178],"study":[25],"evaluated":[26],"clinical":[28,86],"significance":[29],"these":[31],"antibodies":[32,41,112,134,171,188],"rheumatoid":[36],"arthritis":[37],"(RA).":[38],"METHODS:":[39],"Antiinfliximab":[40],"were":[42,72,80,102,117],"measured":[43],"using":[44],"newly":[46],"developed":[47,169],"radioimmunoassay":[48],"cohort":[51],"51":[53],"consecutive":[54],"RA":[57,164],"treated":[58,166],"followup":[63],"1":[65],"year.":[66],"In":[67,157],"addition,":[68],"serum":[69],"infliximab":[70,101,168],"levels":[71],"determined":[73],"by":[74],"enzyme-linked":[75],"immunosorbent":[76],"assay.":[77],"The":[78],"results":[79],"analyzed":[81],"relation":[83],"to":[84,88,91,180,195],"response":[87,194],"treatment":[89],"according":[90],"European":[93],"League":[94],"Against":[95],"Rheumatism":[96],"criteria.":[97],"RESULTS:":[98],"Antibodies":[99],"detected":[103],"22":[105,137],"(43%).":[107],"Patients":[108],"without":[109],"detectable":[110,132,153],"antiinfliximab":[111,133,154,170,187],"(n":[113],"=":[114,140],"29":[115,126],"[57%])":[116],"significantly":[118],"more":[119],"often":[120],"classified":[121],"as":[122],"responders":[123],"(20":[124],"[69%])":[127],"compared":[128],"(8":[135],"[36%];":[138],"P":[139],"0.04).":[141],"Three":[142],"had":[144,152],"an":[145],"infusion-related":[146],"allergic":[147],"reaction,":[148],"all":[149],"whom":[151],"CONCLUSION:":[156],"this":[158],"study,":[159],"nearly":[160],"half":[161],"within":[172],"first":[174],"year":[175],"treatment.":[177,196],"seems":[179],"be":[181],"clinically":[182],"relevant,":[183],"since":[184],"development":[185],"is":[189],"associated":[190],"reduced":[193]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":19},{"year":2019,"cited_by_count":21},{"year":2018,"cited_by_count":23},{"year":2017,"cited_by_count":28},{"year":2016,"cited_by_count":31},{"year":2015,"cited_by_count":49},{"year":2014,"cited_by_count":26},{"year":2013,"cited_by_count":36},{"year":2012,"cited_by_count":39}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}